Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Equity

Direct

Index Funds

NAV as on 06-11-2024

₹ 20.3

0.5%

1D

Inception Returns

19.2%

/yr

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund. This fund was started on 26 October, 2020. The fund is managed by Bhavesh Jain. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has ₹162 Cr worth of assets under management (AUM) as on Sep 2024 and is less than category average.
  2. The fund has an expense ratio 0.5.

Returns

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 19.21% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 42.28% and 17.14% respectively.

Holdings

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Max Healthcare Institute Ltd Ordinary Shares, Apollo Hospitals Enterprise Ltd

Taxation

As it is a index funds mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has no lock in period.

Historical NAV & Returns

Annualised

zero opening, trading, fund transfer fee
2912 people have invested ₹ 23.2L in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth in the last three months

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Overview

Expense ratio0.5%
Benchmark
MSCI Ind Dom & Wld HealthC 45 NR INR
AUM₹162 Cr
Inception Date26 October, 2020
Min Lumpsum/SIP₹100/₹100
Exit Load0%
Lock InNo Lock-in
TurnOver
7.8%
STCGRedeeming before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Fund Distribution

as on (30-Sep-24)

  • Equity 99.9%

  • Debt & Cash 0.1%

Large cap
43.3%

Mid cap
24.2%

Small cap
4.7%

Sector Allocation

Sep'24

Aug'24

Jul'24

Health
100%
All changes are between Jul'24 and Sep'24
Sep'24
Aug'24
Jul'24
Fund Returns
0.62%
6.10%
6.28%
Nifty 50
2.11%
0.90%
3.35%
  • This fund’s returns stands at 0.62% whereas the fund’s underlying benchmark Nifty 50 returns stands at 2.11% as on Sep'24
  • This fund underperformed Nifty 50 by 1.49% in Sep'24
Parameters
Sep'24
Aug'24
Jul'24
AUM
₹ 162 Cr
₹ 159.6 Cr
₹ 148.4 Cr
  • AUM of the fund stands at 162 Cr as of Sep'24
  • AUM increased by 2.5 Cr between Sep'24 and Aug'24
Top Stocks bought last month
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 5.19% to 5.88%
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 5.19% to 5.88%
Divi's Laboratories Ltd's allocation increased from 4.67% to 4.91%
Divi's Laboratories Ltd's allocation increased from 4.67% to 4.91%
Sun Pharmaceuticals Industries Ltd's allocation increased from 13.65% to 13.87%
Sun Pharmaceuticals Industries Ltd's allocation increased from 13.65% to 13.87%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 6.74 % to 6.59 %
Cipla Ltd's allocation decreased from 6.74 % to 6.59 %
Dr Reddy's Laboratories Ltd's allocation decreased from 6.48 % to 5.92 %
Dr Reddy's Laboratories Ltd's allocation decreased from 6.48 % to 5.92 %
Lupin Ltd's allocation decreased from 3.97 % to 3.8 %
Lupin Ltd's allocation decreased from 3.97 % to 3.8 %
Mid Cap allocation has gone up from 24.2% to 24.2%
Mid Cap allocation has gone up from 24.2% to 24.2%
Large Cap allocation has gone up from 41.6% to 43.3%
Large Cap allocation has gone up from 41.6% to 43.3%
Small Cap allocation has gone down from 5.5% to 4.7%
Small Cap allocation has gone down from 5.5% to 4.7%
Cash allocation has gone down from 0.3% to 0.1%
Cash allocation has gone down from 0.3% to 0.1%

Top Sector in September was Health

Sep'24
Health
100%
Aug'24
Health
100%
Fund
Sep'24
Aug'24
Jul'24
No of Holdings
49
50
50
Top 5 Company Concentration
37.7%
37.6%
38.4%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (13.9%)
Sun Pharmaceuticals Industries Ltd (13.7%)
Sun Pharmaceuticals Industries Ltd (13.7%)
No of Sectors
1
1
1
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (100%)
Health (100%)
Health (100%)
Loading...
We are taking more time than usual
Bhavesh Jain
Bhavesh Jain
Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth, since 1 October 2021
Fund House
Edelweiss Asset Management Limited
Total AUM
₹1.03L Cr
as on 30-Sep-2024
Address
Edelweiss House, Off C.S.T. Road, Kalina
Phone
91-22-40979900
Website
investor.amc@edelcap.com

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 19.21% since inception which is more than its category average return of 17.31%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.92% in Equity, 0% in Debt and 0.08% in Cash related instruments
AUM size ₹162 Cr

AUM size ₹162 Cr

This fund has AUM of ₹162 Cr which is less than its category average of ₹ 847 Cr
Expense Ratio 0.5%

Expense Ratio 0.5%

This fund has an expense ratio of 0.5% which is less than its category average expense ratio of 0.51%

Frequently Asked Questions for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

The current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is ₹20.3 as on 06-Nov-2024.
Existing (Absolute + CAGR) as on 06-Nov-2024.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-0.28%
-0.28%
6 Month Returns
16.31%
16.31%
1 Year Returns
42.28%
42.28%
3 Years Returns
60.75%
17.14%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.5% as on October 2024
₹162 Cr as on October 2024
Sun Pharmaceuticals Industries Ltd(13.87%), Cipla Ltd(6.59%), Dr Reddy's Laboratories Ltd(5.92%), Max Healthcare Institute Ltd Ordinary Shares(5.88%), Apollo Hospitals Enterprise Ltd(5.46%) as on October 2024
The alpha ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
-
-
-
As on October 2024
The alpha for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated against MSCI Ind Dom & Wld HealthC 45 NR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
-
-
-
As on October 2024
The Beta for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
2.59
0.81
-
As on October 2024
The sharpe ratio for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
12.52
13.68
-
As on October 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.4 as on October 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Bhavesh Jain is the fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
The Exit load of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is 0%